Ed Silverman's Pharmalot blog had this post this morning. The US Justice Department and the SEC will be looking into relationships of pharmaceutical companies with foreign goverments. As reported over the past several weeks, clinical trial work is increasingly being done outside the US for drugs that ultimately end up being marketed in the US. This puts additional pressure on the FDA to try to monitor these trials.
As described last week, a new Senate bill will among other things give the FDA more oversight and enforcement powers relative to foreign drug trials, and increase its resources for oversight.
Posted by Bruce Lehr August 9th 2010.